The Patent Finder

Faes Farma, S.A.

Also on record
Records under this name other than the patents Faes Farma, S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.

Showing 1 to 5 of 5 · Back to Faes Farma, S.A.

PatentTitleStatus Expires Confidence
US 11,370,742Process and Intermediates for the Preparation of Bilastine
Lapsed on the fee record
Ended Jun 28, 2026 · High confidence
Lapsed on the fee recordEnded Jun 28, 2026High confidence
US 7,612,095Polymorph of 4-[2-[4-[1-(2-ethoxyethyl)-1H-benzimidazole-2-yl]-1-piperidinyl]ethyl]-αα-dimethyl-benzeneacetic acid
Term ended
Term ended Sep 6, 2023 · From the USPTO record
Term endedTerm ended Sep 6, 2023From the USPTO record
US 7,781,5945-(4-methanesulfonyl-phenyl)-thiazole derivatives for the treatment of acute and chronic inflammatory diseases
Lapsed on the fee record
Ended Aug 24, 2018 · From the USPTO record
Lapsed on the fee recordEnded Aug 24, 2018From the USPTO record
US 8,492,4115-(4-methanesulfonyl-phenyl)-thiazole derivatives for the treatment of acute and chronic inflammatory diseases
Lapsed on the fee record
Ended Jul 23, 2017 · From the USPTO record
Lapsed on the fee recordEnded Jul 23, 2017From the USPTO record
US 5,877,187Benzimidazole derivatives with antihistaminic activity
Term ended
Term ended no later than Mar 2, 2019 · Low confidence
Term endedTerm ended no later than Mar 2, 2019Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited